Cargando…
PEG Minocycline-Liposomes Ameliorate CNS Autoimmune Disease
BACKGROUND: Minocycline is an oral tetracycline derivative with good bioavailability in the central nervous system (CNS). Minocycline, a potent inhibitor of matrix metalloproteinase (MMP)-9, attenuates disease activity in experimental autoimmune encephalomyelitis (EAE), an animal model of multiple s...
Autores principales: | Hu, Wei, Metselaar, Josbert, Ben, Li-Hong, Cravens, Petra D., Singh, Mahendra P., Frohman, Elliot M., Eagar, Todd N., Racke, Michael K., Kieseier, Bernd C., Stüve, Olaf |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2613526/ https://www.ncbi.nlm.nih.gov/pubmed/19127301 http://dx.doi.org/10.1371/journal.pone.0004151 |
Ejemplares similares
-
Rituximab Therapy Reduces Organ-Specific T Cell Responses and
Ameliorates Experimental Autoimmune Encephalomyelitis
por: Monson, Nancy L., et al.
Publicado: (2011) -
The neonatal CNS is not conducive for encephalitogenic Th1 T cells and B cells during experimental autoimmune encephalomyelitis
por: Cravens, Petra D, et al.
Publicado: (2013) -
TLR3 agonism re‐establishes CNS immune competence during α4‐integrin deficiency
por: Hussain, Rehana Z., et al.
Publicado: (2018) -
CD11c(+)CD88(+)CD317(+) myeloid cells are critical mediators of persistent CNS autoimmunity
por: Manouchehri, Navid, et al.
Publicado: (2021) -
Pharmacological prion protein silencing accelerates central nervous system autoimmune disease via T cell receptor signalling
por: Hu, Wei, et al.
Publicado: (2010)